XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.20.4

Stock-Based Compensation | 6 Months Ended
--- | ---
Dec. 31, 2020
Stock-Based Compensation [Abstract] |
Stock-Based Compensation | 13.Stock-based compensation The Company’s Amended and Restated 2015 Stock Incentive Plan and the vesting terms of certain stock-based awards granted are described in Note 18 to the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the year ended June 30, 2020. Stock option and restricted stock activity Options The following table summarizes stock option activity for the six months ended December 31, 2020 and 2019:
|  |  |  |  |  |  | Number of shares |  |  | Weighted average exercise price ($) |  |  | Weighted average remaining contractual term (in years) |  |  | Aggregate intrinsic value ($'000) |  | Weighted average grant date fair value ($)
| Outstanding - June 30, 2020 |  | 1,331,651 |  |  | 5.83 |  |  | 7.56 |  |  | - |  | 2.01
|  | Granted - August 2020 |  | 150,000 |  |  | 3.50 |  |  | 3.00 |  |  | 166 |  | 1.11
|  | Granted - November 2020 |  | 560,000 |  |  | 3.01 |  |  | 10.00 |  |  | 691 |  | 1.23
|  | Exercised |  | (5,834) |  |  | 3.07 |  |  | - |  |  | 21 |  | -
|  | Forfeited |  | (456,033) |  |  | 7.03 |  |  | - |  |  | - |  | 2.26
|  |  | Outstanding - December 31, 2020 |  | 1,579,784 |  |  | 4.28 |  |  | 8.04 |  |  | 2,104 |  | 1.59
| Outstanding - June 30, 2019 |  | 864,579 |  |  | 7.81 |  |  | 7.05 |  |  | - |  | 2.62
|  | Granted – October 2019 |  | 561,000 |  |  | 3.07 |  |  | 10.00 |  |  | 676 |  | 1.20
|  |  | Outstanding - December 31, 2019 |  | 1,425,579 |  |  | 5.94 |  |  | 7.81 |  |  | 365 |  | 2.07
On August 5, 2020, the Company granted one of its non-employee directors, Mr. Ali Mazanderani, in his capacity as a consultant to the Company, 150,000 stock options with an exercise price of $3.50. These stock options are subject to the non-employee director’s continuous service through the applicable vesting date, and half of the options vest on each of the first and second anniversaries of the grant date. The Company awarded 560,000 and 561,000 stock options to employees during the three and six months ended December 31, 2020 and 2019, respectively. During the six months ended December 31, 2020, the Company’s former chief executive officer forfeited 250,034 stock options with strike prices ranging from $6.20 to $11.23 per share following his separation from the Company. Employees forfeited 205,999 stock options during the three and six months ended December 31, 2020. No stock options were forfeited during the three and six months ended December 31, 2019. The fair value of each option is estimated on the date of grant using the Cox Ross Rubinstein binomial model that uses the assumptions noted in the following table. The estimated expected volatility is calculated based on the Company’s 750-day volatility. The estimated expected life of the option was determined based on historical behavior of employees who were granted options with similar terms. The table below presents the range of assumptions used to value stock options granted during the six months ended December 31, 2020 and 2019:
|  |  |  |  | Six months ended |
|  |  |  |  | December 31, |
|  |  |  |  |  | 2020 |  |  |  | 2019 |
| Expected volatility |  | 62 | % |  |  | 57 | %
| Expected dividends |  | 0 | % |  |  | 0 | %
| Expected life (in years) |  | 3 |  |  |  | 3 |
| Risk-free rate |  | 0.19 | % |  |  | 1.57 | %
13.Stock-based compensation (continued) Stock option and restricted stock activity (continued) Options (continued) The following table presents stock options vested and expected to vest as of December 31, 2020:
|  |  |  |  |  |  | Number of shares |  |  | Weighted average exercise price ($) |  |  | Weighted average remaining contractual term (in years) |  |  | Aggregate intrinsic value ($’000) |
| Vested and expecting to vest - December 31, 2020 |  |  | 1,579,784 |  |  | 4.28 |  |  | 8.04 |  |  | 2,104 |
These options have an exercise price range of $3.01 to $11.23. The following table presents stock options that are exercisable as of December 31, 2020:
|  |  |  |  |  |  | Number of shares |  |  | Weighted average exercise price ($) |  |  | Weighted average remaining contractual term (in years) |  |  | Aggregate intrinsic value ($’000) |
| Exercisable - December 31, 2020 |  |  | 472,299 |  |  | 6.37 |  |  | 7.17 |  |  | 274 |
During the three months ended December 31, 2020, ,181333 stock options became exercisable. No stock options became exercisable during the three months ended December 31, 2019. During the six months ended December 31, 2020 and 2019, respectively, 337,666 and 170,335 stock options became exercisable. The Company issues new shares to satisfy stock option exercises. Restricted stock The following table summarizes restricted stock activity for the six months ended December 31, 2020 and 2019:
|  |  |  |  |  |  | Number of shares of restricted stock |  |  |  | Weighted average grant date fair value ($’000) |  |
| Non-vested – June 30, 2020 |  |  | 1,115,500 |  |  |  | 5,354 |  |
|  | Total vested |  |  | (311,300) |  |  |  | (1,037) |  |
|  |  | Vested – August 2020 |  |  | (244,500) |  |  |  | (812) |  |
|  |  | Vested – September 2020 - accelerated vesting |  |  | (66,800) |  |  |  | (225) |  |
| Forfeitures |  |  | (510,200) |  |  |  | (1,766) |  |
|  |  | Non-vested – December 31, 2020 |  |  | 294,000 |  |  |  | 994 |  |
| Non-vested – June 30, 2019 |  |  | 583,908 |  |  |  | 3,410 |  |
|  |  |  | Non-vested – December 31, 2019 |  |  | 583,908 |  |  |  | 3,410 |  |
During the six months ended December 31, 2020, 244,500 shares of restricted stock with time-based vesting conditions vested. In connection with the Company’s former chief executive officer’s separation, the Company agreed to accelerate the vesting of 66,800 shares of restricted stock which were granted in February 2020, and which were subject to time-based vesting. These shares of restricted stock vested on September 30, 2020. The ,510200 shares of restricted stock that were forfeited during the six months ended December 31, 2020, includes 375,200 shares of restricted stock forfeited by the Company’s former chief executive officer upon his separation from the Company and 30,000 shares of restricted stock forfeited by an executive officer as the market condition (related to share price performance) was not achieved. 13.Stock-based compensation (continued) Stock-based compensation charge and unrecognized compensation cost The Company recorded a stock-based compensation charge, net during the three months ended December 31, 2020 and 2019, of $0.2 million and $0.4 million, respectively, which comprised:
|  |  |  |  |  | Total charge |  | Allocated to cost of goods sold, IT processing, servicing and support |  | Allocated to selling, general and administration |
| Three months ended December 31, 2020 |  |  |  |  |  |  |  |  |  |
|  |  | Stock-based compensation charge |  | $ | 246 |  | $ | - |  | $ | 246 |
|  |  | Reversal of stock compensation charge related to stock options and restricted stock forfeited |  |  | (14) |  |  | - |  |  | (14) |
|  |  |  | Total - three months ended December 31, 2020 |  | $ | 232 |  | $ | - |  | $ | 232 |
| Three months ended December 31, 2019 |  |  |  |  |  |  |  |  |  |
|  |  | Stock-based compensation charge |  | $ | 436 |  | $ | - |  | $ | 436 |
|  |  |  | Total - three months ended December 31, 2019 |  | $ | 436 |  | $ | - |  | $ | 436 |
The Company recorded a stock-based compensation charge, net during the six months ended December 31, 2020 and 2019, of $0.6 million and $0.8 million respectively, which comprised:
|  |  |  |  |  | Total charge |  | Allocated to cost of goods sold, IT processing, servicing and support |  | Allocated to selling, general and administration |
| Six months ended December 31, 2020 |  |  |  |  |  |  |  |  |  |
|  |  | Stock-based compensation charge |  | $ | 928 |  | $ | - |  | $ | 928 |
|  |  | Reversal of stock compensation charge related to stock options and restricted stock forfeited |  | $ | (297) |  | $ | - |  | $ | (297) |
|  |  |  | Total - six months ended December 31, 2020 |  | $ | 631 |  | $ | - |  | $ | 631 |
| Six months ended December 31, 2019 |  |  |  |  |  |  |  |  |  |
|  |  | Stock-based compensation charge |  | $ | 823 |  | $ | - |  | $ | 823 |
|  |  |  | Total - six months ended December 31, 2019 |  | $ | 823 |  | $ | - |  | $ | 823 |
The stock-based compensation charges have been allocated to selling, general and administration based on the allocation of the cash compensation paid to the relevant employees. As of December 31, 2020, the total unrecognized compensation cost related to stock options was approximately $1.3 million, which the Company expects to recognize over approximately three years. As of December 31, 2020, the total unrecognized compensation cost related to restricted stock awards was approximately $0.7 million, which the Company expects to recognize over approximately two years. As of December 31, 2020, and June 30, 2020, respectively, the Company recorded a deferred tax asset of approximately $0.04 million and $0.4 million, related to the stock-based compensation charge recognized related to employees of Net1. As of December 31, 2020, and June 30, 2020, respectively, the Company recorded a valuation allowance of approximately $0.04 million and $0.4 million, related to the deferred tax asset because it does not believe that the stock-based compensation deduction would be utilized as it does not anticipate generating sufficient taxable income in the United States. The Company deducts the difference between the market value on the date of exercise by the option recipient and the exercise price from income subject to taxation in the United States.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration